For CML LSCs, we might speculate that there is inappropriate/excessive buffering of fate options and that myeloid fate is facilitated by BCR-ABLp210 or some other event. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.